Mucinous cystic neoplasm of the pancreas in a male patient by Tokuyama, Yasuharu et al.
[Rare Tumors 2011; 3:e14] [page 41]
Mucinous cystic neoplasm of
the pancreas in a male patient 
Yasuharu Tokuyama, Shinji Osada,
Yuichi Sanada, Takao Takahashi, 
Kazuya Yamaguchi, Kazuhiro Yoshida
Department of Surgical Oncology,
Graduate School of Medicine, Gifu
University, Gifu, Japan
Abstract 
Mucinous cystic neoplasms (MCNs) make up
a  morphologic  family  of  similar  appearing
tumors arising in the ovary and various extrao-
varian organs such as pancreas, hepatobiliary
tract  and  mesentery.  MCNs  of  the  pancreas
occur almost exclusively in women. Here, we
report a rare case of MCN in a male patient. A
39-year-old man was admitted to our hospital
with  the  chief  complaint  of  back  pain.
Abdominal  computed  tomography    revealed  a
multilocular cyctic mass 6.3 cm in diameter in
the pancreatic tail. In addition, the outer wall
and septae with calcification were demonstrat-
ed in the cystic lesion. On magnetic resonance
imaging , the cystic fluid had low intensity on
T1-weighted imaging and high intensity on T2-
weighted  imaging.  Endoscopic  retrograde
cholangio-pancreatography  (ERCP)  showed
neither  communication  between  the  cystic
lesion  and  the  main  pancreatic  duct  nor
encasement  of  the  main  pancreatic  duct.
Endoscopic ultrasonography  revealed neither
solid component nor thickness of the septae in
the cystic lesion. Consequently, we performed
distal pancreatectomy with splenectomy under
the  diagnosis  of  cystic  neoplasia  of  the  pan-
creas.  Histopathologically,  the  cystic  lesion
showed  two  distinct  component:  an  inner
epithelial  layer  and  an  outer  densely  cellular
ovarian-type stromal layer. Based on these find-
ings, the cystic lesion was diagnosed as MCN.
Introduction
Mucinous  cystic  neoplasms  (MCNs)  have
been defined as large, separated, thick-walled
cysts without connection to the pancreas duct
system.1 Based on the WHO criteria in 1996,
the study for 130 cases of MCN with ovarian
type  stroma  (OS)  indicated  to  be  female
patients  appearances  in  whole  cases  and
body/tail location in almost.2 Therefore, as a
rough rule for pancreas cystic neoplasms, in
male and in the head of the pancreas are like-
ly to be IPMNs, whereas cyctic lesions in the
body/tail in female may be either an MCN or
IPMN.3 And, in the past several years, muci-
nous cystic neoplasms of the pancreas have
been  diagnosed  more  and  more  frequently.
Then  it  has  become  crucial  for  physicians
working in this field to have a clear under-
standing of the biology on these tumors. From
recent  our  experience  for  a  male  case  with
MCN, which is quite rare, diagnostic evalua-
tion and therapeutic procedures including sur-
gical indication will be argued with the refer-
ences.   
Case Report
A 39-year-old man was admitted to our hos-
pital  with  the  chief  complaint  of  back  pain.
There was no history of previous abdominal
imaging examinations, and another abdominal
episode,  such  as  sudden  abdominal  pain,
abdominal trauma, or abdominal operation. He
was just social drinker of alcohol and was not
smoker.  On  physical  examination,  abdomen
was  soft  and  flat,  and  no  tenderness  was
noticed. Laboratory tests showed an elevation
of both AST, up to 39 IU/l (normal≦35 IU/L),
and ALT,up to 56 IU/L (normal≦40 IU/L). The
other  data  including  tumor  markers  (CEA,
CA19-9  and  DUPAN-2)  were  within  normal
range. Abdominal CT revealed a multilocular
cyctic mass, 6.3 cm in diameter, with wall cal-
cification in the pancreatic tail (Figure 1). On
MRI, the cystic lesion was hypointense in T1-
weighted  imaging  and  hyperintense  in  T2-
weighted  imaging  with  low  intense  capsule
and septum (Figure 2 a,b). ERCP showed nei-
ther communication between the cystic lesion
and the main pancreatic duct nor encasement
nor interruption of the main pancreatic duct.
Endoscopic  ultrasonography  revealed  neither
solid component nor thickness of the septae in
the  cystic  lesion.  Consequently,  under  the
diagnosis of neoplastic cyst of the pancreas,
such  as  lymph  epithelial  cyst,  serous  cystic
neoplasm, branched-type lesion of IPMN, cys-
tic change of endocrine tumor, and epidermoid
cyst derived from accessory spleen in the pan-
creas,  distal  pancreas  with  spleen  was
removed. Macroscopically (Figure 3), the cys-
tic  lesion,  measuring  for  6.5¥5.8¥5.2  cm  in
size, was round with a smooth surface and was
surrounded by normal pancreatic tissue. The
cut surface demonstrated a multilocular cystic
pattern containing thick yellowish mucin, and
the lesion was surrounded by a fibrous cap-
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Figure 1. Abdominal CT revealed a multi-
locular  cyctic  mass,  6.3  cm  in  diameter,
with wall calcification and no solid com-
ponent in the pancreatic tail. 
Figure  2.  Magnetic  resonance  imaging
showed  that  the  cystic  lesion  was
hypointense in T1-weighted imaging (a) and
hyperintense in T2-weighted imaging with
low intense capsule and septum (b).[page 42] [Rare Tumors 2011; 3:e14]
sule. There was neither mural nodule nor pap-
illary  projections  inside  the  cystic  lesion.
Microscopically (Figure 4 a,b), the cystic lesion
showed  two  distinct  component;  an  inner
mucinous epithelial layer and an outer dense-
ly cellular stromal layer. The mucinous  epithe-
lium showed no cytological atypia and did not
infiltrate into the stromal layer. This stromal
layer  was  consisted  of  spindle-shaped  cells
with round to oval nucrei and a small amount
of cytoplasm, suggesting the finding for OS.
From the immune-histopathological staining,
the stromal layer was detected for negative on
both estrogen and/or progesterone receptors. 
In  addition,  there  was  no  communication
between the cystic lesion and the ductal sys-
tem.  According  to  these  findings,  the  cystic
lesion was diagnosed for MCN of the pancreas.
The patient was discharged from the hospital
without any events. And, on these 14 months,
any recurrence signs have not been detected.
Discussion
Mucin-producing  cystic  neoplasms  of  the
pancreas  have  developed  a  well-recognized
entity. In the two decades, due to the utility of
high-resolution  abdominal  imaging  tech-
niques, similar cystic lesions of the pancreas
are increasingly identified incidentally,4 and a
large number of patients have undergone sur-
gical  resection.5 In  1996,  under  the  aim  to
describe and categorize the cystic lesions of
the pancreas, the WHO classification  defined
MCN as cystic epithelial neoplasms composed
of  columnar,  mucin-producing  epithelium,
supported by OS.6 The OS is known for forming
a band of densely packed spindle cells beneath
the epithelium; its presence has become a crit-
ical requirement as MCN. Then, the MCN was
estimated for the different concept from IPMN
in the past categories for cystic lesion. And, the
Armed  Forces  Institute  of  Pathology  (AFIP)
classification  also  added  the  finding  for  no
communication with the pancreas ductal sys-
tem.7 Taken together, no doubt to diagnose the
present  cystic  lesion  as  MCN  was  detected.
Although the developmental process of MCN
has not been well understood, it is indicated to
originate  from  remnant  primordial  gonadal
cells that migrated to the pancreas, because
the left primordial gonad and dorsal pancreas
anlage lie side by side during embryogenesis.8
The dorsal anlage develops the body and tail of
the pancreas; therefore the MCN was frequent-
ly raised in the dorsal pancreas and detected in
female. Indeed, from the past reports for 130
cases2 and 56 cases8 with MCN, no male case
has  been  demonstrated.  According  to  the
recent research for pancreas cystic tumors by
the  Japan  Pancreas  Society  (1992-2001),
detected 179 cases with MCN were female in
whole.9 To diagnose the cystic lesion for MCN,
the presence of OS pattern should be impor-
tant;  if  limiting  the  tumor  with  OS  but  not
without  OS,  all  male  cases  were  excluded.7
Therefore, it is likely that many of the MCN
cases reported in male in the early literature
were IPMN or other cystic lesion.1 To the best
of our knowledge, 2 male cases with WHO cri-
teria-mediated MCN have been reported for a
43-year-old  man  in  199810 and  a  25-year-old
man in 2005.11 Both of them, the cystic lesions
were located in pancreas tail, 2.5 cm and 5 cm
in size, and the expressions of estrogen/prog-
esterone receptor were demonstrated in stro-
mal  component  immunohistochemistly.  By
contrast, the present MCN was found to have
neither estrogen nor progesterone receptors.
These rare patterns become the originality of
MCNs to be unclear, and then further investi-
gations should be continued.
Similar to IPMNs, MCNs have been divided
into those with low-grade, moderate grade and
high grade dysplasia, and invasive adenocari-
cinoma. The prevalence of invasive carcinoma
reported  in  MCNs  has  varied  widely  in  the
range of 6-36%.2,8,12 The MCNs are commonly
solitary  and  the  recurrence  does  not  occur
after complete resection.13 The biological and
clinical behavior of invasive adenocarcinoma
arising  from  the  background  of  cystic  neo-
plasms might be different from the common
invasive  ductal  adenocarcinoma.  Infiltrating
carcinoma  associated  with  MCNs,  and  also
IPMNs, appears to grow less aggressively and
to have a lower incidence of peritoneal and
vascular invasion.14 Then, the patients suffer-
ing  from  malignant  cystic  neoplasms  of  the
pancreas are likely to get a better for survival
after resection than patients with ductal ade-
nocasrcinoma. The patients with ductal pan-
creatic  cancer  show  around  20%  for  5-years
survival  even  after  curative  resection,  while
the  patients  with  malignant  MCNs  demon-
strate  over  50%  for  5-years  survival  rate.15
According to the Japan Pancreas Society also,
the 5-year survival rate of MCN patients was
100% in adenoma to minimally invasive carci-
noma cases, and 57.7% in invasive carcinoma
cases.9 In spite of low grade malignant poten-
tial,16,17 a common recommendation should be
removal  for  all  mucin-producing  neoplasms
because of the fear of ultimately developing
cancer.2,18 For the surgical procedures, the con-
sideration about not only operative indications
but also care for safety might be argued.19,20
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